Pharmaceutical suspension tablet compositions
US5955107A · kind A · utility
36Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 1997 |
| Grant date | Sep 21, 1999 |
| Priority date | — |
| Expiry date | Dec 12, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Rapidly disintegrating and readily suspendible tablets and their method of preparation are disclosed in which there is a therapeutic amount of a pharmacologically active ingredient, 1 to 6 percent croscarmellose sodium, 10 to 50 percent microcrystalline cellulose, and 10 to 50 percent of a coprocessed additive consisting essentially of 75 to 95 percent microcrystalline cellulose and 5 to 25 percent calcium, sodium alginate complex. The tablets are suitable for oral administration of measured-dose suspensions of either water soluble or water insoluble pharmaceuticals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.